Case Reports in Immunology (Jan 2020)

The Natural History of X-Linked Lymphoproliferative Disease (XLP1): Lessons from a Long-Term Survivor

  • Yike Jiang,
  • Mihail Firan,
  • Sarada L. Nandiwada,
  • Anaid Reyes,
  • Rebecca A. Marsh,
  • Tiphanie P. Vogel,
  • Joud Hajjar

DOI
https://doi.org/10.1155/2020/8841571
Journal volume & issue
Vol. 2020

Abstract

Read online

X-linked lymphoproliferative disease (XLP1) is a rare primary immunodeficiency characterized by EBV-triggered immune dysregulation, lymphoproliferation, dysgammaglobulinemia, and lymphoma. Early childhood mortality from overwhelming inflammation is expected in most patients. The only curative therapy is hematopoietic stem cell transplant (HSCT); however, whether to perform HSCT on an asymptomatic patient remains debatable. This uncertainty arises because the natural history of XLP1 patients without transplantation is not clear. In this case report, we present the natural history of XLP1 in a 43-year-old male patient who did not receive HSCT. We also review the literature on untransplanted XLP1 patients who lived into mid-adulthood. Despite surviving childhood presentations that are typically fatal, we found that these rare patients remain susceptible to manifestations of XLP1 decades later.